Skip to content

Moving Closer to Affordable Advanced Therapies: A Review of Current Trends in Downstream Processing

By M T

Originally published in International Biopharmaceutical Industry Journal, Volume 7, Issue 4. Tozaro’s Head of Cell and Gene Therapy Applications, Abdullah Sufan, discusses the latest trends shaping downstream processing and the technologies helping to make advanced therapies more affordable and scalable. This review explores the evolving landscape of viral vector purification, highlighting emerging approaches that can … Continued

Behind the Batch Episode 2 – Giuliana Vallanti

By M T

Behind the Batch spotlights the moments that shape the people pioneering cell and gene therapy. Failed batches, first viable runs, tech transfers, and everything in between. In episode 2, our host Alex Shephard chats with Giuliana Vallanti, SVP Operations and R&D at AGC Biologics. She discusses two decades in cell and gene therapy, from process … Continued

Tozaro Limited raises £6m/$8.2m to accelerate development & commercialization of Smart Polymer™ affinity ligands in cell & gene therapy

By M T

BEDFORD, UK, 16th February 2026 / Tozaro Limited, a company leveraging molecular modelling and ML to design and develop stable, cost-effective, specific and selective polymer-based ligands, announces a £6m/$8.2m funding round. The investment was led by Mercia Ventures, which was investing from the Midlands Engine Investment Fund II and from its own funds, alongside other … Continued

Tozaro announces formation of Technical Advisory Board to support commercialization of Smart Polymers in cell and gene therapy bioprocessing

By Keli

Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, today announced the formation of its Technical Advisory Board (TAB). The group will provide strategic guidance around commercialization and further development of the Company’s Smart Polymer platform, and its innovative application to significantly improve cell and gene therapy (CGT) chromatography and … Continued

Novel synthetic affinity reagents for lentivirus analytics and capture chromatography – Presented at The Bioprocessing Summit 2024

By Keli

First presented at The Bioprocessing Summit 2024, this poster introduces a new suite of synthetic affinity reagents targeting VSV-G, a lentivirus envelope protein for viral vector analytics and purification. Smart polymers targeting VSV-G accurately detect lentivirus in Octet® BLI platform and show promise for novel capture chromatography These synthetic affinity reagents have been designed to … Continued

MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification

By Keli

Bedfordshire, UK, 06 August 2024: MIP Discovery today announced the Company’s rebrand to Tozaro, completing its transition to becoming a technology innovator in the cell and gene therapy (CGT) bioprocessing sector. The rebrand comes at a time of significant growth for the Company, following the refocusing of its mission to improve downstream processing within the … Continued